A Pilot Study Using Photo-plethysmographic (PPG) Camera

This study has been completed.
Sponsor:
Collaborator:
Children’s Hospital of Orange County
Information provided by (Responsible Party):
Montana Compton, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT01166867
First received: July 20, 2010
Last updated: October 28, 2011
Last verified: October 2011
  Purpose

The researcher want to use video signals to monitor heart rate, respiration rate and oxygen saturation using Photo-plethysmography (PPG) as the underlying mechanism for the method: periodic changes in skin reflectance, induced by the cardio-vascular wave, are measured using light.


Condition Intervention
Assessment Infant Vital Sign
Device: monitoring

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Photo-plethysmographic (PPG) Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants.

Resource links provided by NLM:


Further study details as provided by University of California, Irvine:

Enrollment: 10
Study Start Date: September 2009
Study Completion Date: August 2010
Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
assessment Device: monitoring
monitoring vital sign in infant

Detailed Description:

The Researcher want to use ambient light to monitor heart rate, respiration rate and oxygen saturation (SpO2) in infant patients in a hospital setting. The plethysmographic signal is typically strong on children. This provides a reliable heart rate monitor. However, to measure oxygen saturation, a quantitative value of the strength at two wavelength regions (green and red) is required. It is also not known if the normal ambient light is spectrally appropriate to analyze the video signals for oxygenation. With the current prototype of our system, we can monitor heart rate reliably and estimate oxygen saturation in adults, using normal artificial light or daylight, entering through a window.

  Eligibility

Ages Eligible for Study:   up to 12 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

infant

Criteria

Inclusion Criteria:

  • infant and toddler

Exclusion Criteria:

  • non-infant
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01166867

Locations
United States, California
Children's Hospital of Orange County
Orange, California, United States, 92868
Sponsors and Collaborators
Montana Compton
Children’s Hospital of Orange County
Investigators
Principal Investigator: Stuart Nelson, M.D, PhD Beckman Laser Institute University of California Irvine
  More Information

No publications provided

Responsible Party: Montana Compton, Administrative Nurse Research Coordinator Beckman Laser Institute, University of California, Irvine
ClinicalTrials.gov Identifier: NCT01166867     History of Changes
Other Study ID Numbers: LAMMP-30139; HS#2009-7046
Study First Received: July 20, 2010
Last Updated: October 28, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, Irvine:
assessment

ClinicalTrials.gov processed this record on July 20, 2014